MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.290
-0.150 (-6.15%)
At close: Mar 30, 2026, 4:00 PM EDT
2.220
-0.070 (-3.06%)
Pre-market: Mar 31, 2026, 7:43 AM EDT
MDxHealth Employees
MDxHealth had 312 employees as of December 31, 2024. The number of employees increased by 12 or 4.00% compared to the previous year.
Employees
312
Change (1Y)
12
Growth (1Y)
4.00%
Revenue / Employee
$345,753
Profits / Employee
-$107,433
Market Cap
117.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 312 | 12 | 4.00% | 312 | 0 |
| Dec 31, 2023 | 300 | 42 | 16.28% | 300 | 0 |
| Dec 31, 2022 | 258 | 67 | 35.08% | 252 | 6 |
| Dec 31, 2021 | 191 | 14 | 7.91% | 191 | 0 |
| Dec 31, 2020 | 177 | 0 | - | 177 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 883 |
| Burning Rock Biotech | 674 |
| FONAR | 535 |
| Biodesix | 334 |
| Prenetics Global | 285 |
| Personalis | 260 |
MDXH News
- 14 days ago - Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 - GlobeNewsWire
- 4 weeks ago - MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewsWire
- 2 months ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences - GlobeNewsWire
- 3 months ago - Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - GlobeNewsWire
- 4 months ago - MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Angle PLC Announces Strategy Update - Accesswire
- 8 months ago - Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - GlobeNewsWire